Hepatitis C Perspective

 
 
  • The Alcohol Pandemic: Are We Ready for What's Next? Drinking and obesity are on the rise, creating a perfect storm for liver disorders in our patients.
  • DDW 2021 Read clinically focused news coverage of key developments from DDW 2021
  • America's Forgotten History of Supervised Opioid Injection Facilities that would allow people to openly use opioids are igniting controversy today, but were once widespread.
  • Lessons Learned During COVID-19 Will Help Us Better Treat HCV In figuring out how to practice during a pandemic, we may have also learned new skills for monitoring and treating patients with HCV, says Dr William Balistreri.
  • New AASLD Guidelines Reconsider Bleeding Risk in Cirrhosis   Dr David Johnson comments on the paradigm-shifting implications of these guidelines on coagulation and bleeding in patients with cirrhosis.
  • The Likely Future of COVID-19? More Than Polio, Less Than Flu   Is the end goal in the fight against SARS-CoV-2 eradication of the virus or to have numbers similar to that of flu? Neither, says F. Perry Wilson.
  • How Sjogren Syndrome Intersects With COVID-19 Physicians Robert Fox and Alan N. Baer discuss the latest research on Sjogren's, presented at the ACR Convergence virtual meeting.
  • Physicians of the Year 2020: Best and Worst Physicians and other healthcare workers around the world worked tirelessly on the front lines of the COVID-19 pandemic, and hundreds lost their lives as a result. However, with the good comes the bad.
  • Liver Cancer Rates Are Rising; So Is Optimism Around Its Treatment Dr Nancy Reau shares the promising data leading her to believe that the trends around liver cancer can soon be reversed.
  • Vanquishing Hepatitis C: A Remarkable Success Story A look back at one of the singular achievements in medical research of the past 25 years, and what improvements are still to come.
  • AASLD 2020 Read clinically focused news coverage of key developments from AASLD 2020
  • ACG 2020 Read clinically focused news coverage of key developments from ACG 2020
  • Obeticholic Acid for NASH: Revolution or Just a Ripple? With FDA approval likely by year's end, Drs Jason Kramer and Nancy Reau consider what obeticholic acid may mean for this increasingly prevalent disease.
  • DDW 2020 Read clinically focused news coverage of key developments from DDW 2020
  • ILC 2020 Read clinically focused news coverage of key developments from ILC 2020
  • The Promise of Remdesivir for COVID-19 Treatment   WebMD Chief Medical Officer John Whyte talks with Dr Stuart Cohen about remdesivir for the possible treatment of COVID-19 infection, and when we might expect to see the development of a vaccine.
  • The Time to Eradicate Hepatitis C Is Now Dr William Balistreri says new guidelines recommending expansive screening may be daunting, but they are absolutely crucial if we want to progress further.
  • Opioid Use Disorder: Treatment Guide for Nonspecialists It may be impossible to rein in the epidemic of opioid use disorder in the United States unless primary care and other nonspecialists help manage it.
  • Hepatocellular Carcinoma: 5 Things to Know Get up to speed on the latest data surrounding the most common form of liver cancer.
  • GUILD 2020 Read clinically focused news coverage of key developments from GUILD 2020